Your Feed

Filter by
See content from
Back to the latest
Avatar
lilacSeal
Multiple Myeloma Discussion • June 10, 2023
Changing Light Chains & High Ratio Questions
AI-generated title
I am very new to MGUS, just diagnosed. I have a few questions. I've had repeat tests to confirm MGUS but the test results for my light chains seemed to have changed on my last lab report. I've typically had Lamda light chains, but with this recent lab it's showing kappa light chains and no lamda. Has anyone else experienced that? My Kappa:Lamda ratio is high also. Does anyone else here have no M spike? Thank you for sharing. I feel a bit lost at sea.
Avatar
DonBathurst
Multiple Myeloma Discussion • June 8, 2023
Experiencing PSA Swings on MM Therapy?
AI-generated title
I have relapsed and am getting very good results with Pom-Dara-dex. I've just started my 7th Cycle, with Dara now every 4 weeks. My question is about PSA screening. Last year (off therapy in remission), my PSA went over 4. After a 6 month wait, it had moved back to under 4. However, this year (while in therapy again) it went to 20.881 (quite a jump!). But a week later, it was at 7.091. My urologist said that if it was cancer, there would not be that kind of drop. We're going to test again in 3 months and determine next steps. Has anyone had these kinds of swings in PSA while on this or any other MM therapy?
Avatar
BridgetCChalker
Multiple Myeloma Discussion • June 7, 2023
Managing DVRd Induction & Weekend Trips?
AI-generated title
Hi. I hope you’re all having a pleasant day. My boyfriend is starting induction treatment next week with the quad of Dara-Velcade-Rev.-Dex. I think I’ve seen it like DVRd. Do any of you have any experience with this? Are the next couple months ones where he’ll likely need to stay closer to home? He’s been toying with booking some weekend trips. What’s your experience? Thanks in advance for any feedback or suggestions that you might have.
Thumbnail for CAR-T Therapy, CARTITUDE-1 Ciltacabtagene Autoleucel in RRMM Patients | Yi Lin, MD, PhD | ASCO 2023
Playlist: ASCO 2023

CAR-T Therapy, CARTITUDE-1 Ciltacabtagene Autoleucel in RRMM Patients | Yi Lin, MD, PhD | ASCO 2023

Video details & playlist
Thumbnail for Worldwide Drug Toxicity Trends for MM | Shahzad Raza, MD & Majid Jaberi-Douraki, PhD | ASCO 2023
Playlist: ASCO 2023

Worldwide Drug Toxicity Trends for MM | Shahzad Raza, MD & Majid Jaberi-Douraki, PhD | ASCO 2023

Video details & playlist
Thumbnail for Phase 1 Therapy PHE885 BCMA-Directed CAR-T Cell Therapy for RRMM | Adam Sperling, MD, PhD | ASCO 2023
Playlist: ASCO 2023

Phase 1 Therapy PHE885 BCMA-Directed CAR-T Cell Therapy for RRMM | Adam Sperling, MD, PhD | ASCO 2023

Video details & playlist
Thumbnail for DREAMM-3 - Blenrep (Belmaf) vs. PomDex for Relapsed/Refratory Myeloma | Katja Weisel, MD | ASCO 2023
Playlist: ASCO 2023

DREAMM-3 - Blenrep (Belmaf) vs. PomDex for Relapsed/Refratory Myeloma | Katja Weisel, MD | ASCO 2023

Video details & playlist
Thumbnail for Barriers in Accessing Myeloma Care in Special Populations | Shakira Grant, MBBS | ASCO 2023
Playlist: ASCO 2023

Barriers in Accessing Myeloma Care in Special Populations | Shakira Grant, MBBS | ASCO 2023

Video details & playlist